Home › Funds › PAYDEN & RYGEL › JNJ

PAYDEN & RYGEL position in JNJ

JOHNSON & JOHNSON · Health Care

PAYDEN & RYGEL reported holding 64,900 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$17.2M, representing 1.35% of its reported portfolio and ranking #26 among its reported holdings. PAYDEN & RYGEL has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)64.90K sh
Reported value held$17.18M
Portfolio Weight1.35%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PAYDEN & RYGEL's JNJ position evolved

PAYDEN & RYGEL first disclosed a stake in JNJ in Q3 2023 at 78,300 shares (US$12.2M). The position peaked in Q3 2026 at 64,900 shares, worth US$17.2M. Across 13 filings, PAYDEN & RYGEL increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 64,900 shares valued at US$17.2M. Notable position changes include a 52% trim in Q2 2024 (shares rose 11% over the following quarter), a 75% increase in Q1 2025 (shares fell 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 78.30K $12.20M New
Q4 2023 78.30K $12.27M Hold
Q1 2024 90.90K $14.38M Add
Q2 2024 43.80K $6.40M Reduce
Q3 2024 43.80K $7.10M Hold
Q4 2024 37.00K $5.35M Reduce
Q1 2025 64.90K $10.76M Add
Q2 2025 64.90K $9.91M Hold
Q3 2025 64.90K $12.03M Hold
Q4 2025 61.40K $12.71M Reduce
Q1 2026 61.40K $15.01M Hold
Q2 2026 64.90K $16.48M Add
Q3 2026 64.90K $17.18M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has PAYDEN & RYGEL held JNJ?

PAYDEN & RYGEL has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PAYDEN & RYGEL's current position in JNJ?

As of Q3 2026, PAYDEN & RYGEL holds 64.90K shares of JNJ (JOHNSON & JOHNSON), valued at $17.18M, representing 1.35% of its reported portfolio and ranking #26.

Has PAYDEN & RYGEL been buying or selling JNJ?

In the latest 13F filing (Q3 2026), PAYDEN & RYGEL held unchanged its position in JNJ. The position peaked in Q3 2026 at 64.90K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.